Showing results (151-160 of 342) with videos related to

Sort By:
Pageof 35
Endocrinology|September 1, 1979
Effect of stress, adrenocorticotropin or corticosteroid treatment, adrenalectomy, or hypophysectomy on hypothalamic immunoreactive adrenocorticotropin concentrationsD T Krieger, A S Liotta, H Hauser, et al.
Biochemistry|June 8, 1982
Lipid-protein interactions. Effect of apolipoprotein A-I on phosphatidylcholine polar group conformation as studied by proton nuclear magnetic resonanceD J Reijngoud, S Lund-Katz, H Hauser, et al.
Schweizerische Medizinische Wochenschrift|November 8, 1980
[The value and advantage of computer assisted tomography as compared to angiography in evaluating patency of aorto-coronary grafts]H Hauser, J J Perrenoud, P Bopp, et al.
The American Journal of Cardiology|September 18, 2004
Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imagingThomas H Hauser, Sharmila Dorbala, Abdulbaset Sulaiman, et al.
The American Journal of Cardiology|April 28, 2004
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Biochemistry|April 22, 1986
Spontaneous vesiculation of aqueous lipid dispersionsH Hauser, N Gains, H J Eibl, et al.
Science Robotics|November 2, 2020
A soft matter computer for soft robotsM Garrad, G Soter, A T Conn, et al.
Gene|January 1, 1985
Isolation of a functional human interleukin 2 gene from a cosmid library by recombination in vivoW Lindenmaier, K E Dittmar, H Hauser, et al.
The American Journal of Cardiology|June 14, 2003
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutterThomas H Hauser, Duane S Pinto, Mark E Josephson, et al.
Biochemical and Biophysical Research Communications|January 15, 1988
Posttranslational modification of interleukin-2 is a late event during activation of human T lymphocytes by ionophore A23187 and phorbol esterH S Conradt, H Hauser, C Lorenz, et al.
Pageof 35